Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQT1P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Skyrizi 360 mg/2.4 ml on-body injectors valued at $12,467.00, with completion targeted for January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The pharmaceutical product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains its primary distribution operations for federal medical procurement.
This delivery order represents a tactical fulfillment under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. As a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, AmerisourceBergen supplies a comprehensive portfolio of medications and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Skyrizi is a dermatological immunosuppressant used in military medical supply chains to support service member healthcare needs, demonstrating the company's role in delivering specialized pharmaceutical products to support military readiness and personnel wellness.
Quick answers
Who was awarded contract SPE2DR26FQT1P?
SPE2DR26FQT1P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FQT1P worth?
The government has obligated $12,467 on SPE2DR26FQT1P.
Is contract SPE2DR26FQT1P an order under another contract?
Yes. SPE2DR26FQT1P is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT1P competed?
The extent of competition for SPE2DR26FQT1P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award